NCT06696287 The 6-minute Pegboard and Ring Test in Patients with Fibromyalgia Syndrome
| NCT ID | NCT06696287 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kirsehir Ahi Evran Universitesi |
| Condition | Fibromyalgia |
| Study Type | OBSERVATIONAL |
| Enrollment | 28 participants |
| Start Date | 2024-11-27 |
| Primary Completion | 2025-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 28 participants in total. It began in 2024-11-27 with a primary completion date of 2025-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of our study is to investigate the validity and reliability of the 6-minute pegboard and ring test in patients with fibromyalgia syndrome.
Eligibility Criteria
Inclusion Criteria: * Being diagnosed with fibromyalgia syndrome * Being aged 18-65 * Stable use of medication for at least 3 months or longer * Volunteering to participate in the study Exclusion Criteria: * Having a musculoskeletal problem that would prevent being tested * Having cardiopulmonary and neurological disease * Malignancy * Pregnancy
Contact & Investigator
Basak Kavalci Kol
STUDY CHAIR
Kirsehir Ahi Evran University
Frequently Asked Questions
Who can join the NCT06696287 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Fibromyalgia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06696287 currently recruiting?
Yes, NCT06696287 is actively recruiting participants. Contact the research team at mervefirat@ahievran.edu.tr for enrollment information.
Where is the NCT06696287 trial being conducted?
This trial is being conducted at Kırşehir, Turkey (Türkiye).
Who is sponsoring the NCT06696287 clinical trial?
NCT06696287 is sponsored by Kirsehir Ahi Evran Universitesi. The principal investigator is Basak Kavalci Kol at Kirsehir Ahi Evran University. The trial plans to enroll 28 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.